Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Xu, Weihua  [Clear All Filters]
2013
Liu J, Ruan B, You N, Huang Q, Liu W, Dang Z, Xu W, Zhou T, Ji R, Cao Y, et al. Downregulation of miR-200a Induces EMT Phenotypes and CSC-like Signatures through Targeting the β-catenin Pathway in Hepatic Oval Cells. PLoS One. 2013;8(11):e79409.
Wu X, Wang W, Meng C, Yang S, Duan D, Xu W, Liu X, Tang M, Wang H. Regulation of differentiation in trabecular bone‑derived mesenchymal stem cells by T cell activation and inflammation. Oncol Rep. 2013.
2014
Jia J, Feng X, Xu W, Yang S, Zhang Q, Liu X, Feng Y, Dai Z. MiR-17-5p modulates osteoblastic differentiation and cell proliferation by targeting SMAD7 in non-traumatic osteonecrosis. Exp Mol Med. 2014;46:e107.
2016
Kang L, Yao C, Khodadadi-Jamayran A, Xu W, Zhang R, Banerjee NSanjib, Chang C-W, Chow LT, Townes T, Hu K. The universal 3D3 antibody of human PODXL is pluripotent cytotoxic, and identifies a residual population after extended differentiation of pluripotent stem cells. Stem Cells Dev. 2016.
2019
Xu W, Li J, Tian H, Wang R, Feng Y, Tang J, Jia J. MicroRNA‑186‑5p mediates osteoblastic differentiation and cell viability by targeting CXCL13 in non‑traumatic osteonecrosis. Mol Med Rep. 2019.
2021
Yu W, Hu J'an, Le H, Lu Y, Xu W, Yu W, Shen W. Tumstatin attenuates the promotion effect of IL-17 secreted by Th17 cells on the stemness maintenance of glioma cells. Pathol Res Pract. 2021;223:153463.
2023
Jiang K, Liu S, Chen Y, Xu Z, Xu Z, Qian B, Ding Q, Cui H, Sui Y, Cao D, et al. Characterization of TCF-1 and its relationship between CD8+ TIL densities and immune checkpoints and their joint influences on prognoses of lung adenocarcinoma patients. Thorac Cancer. 2023.